Novo Nordisk focuses on relationship marketing while working to strengthen the brand image as a leading provider of innovative treatment solutions.

          Novo Nordisk Pharma (Thailand), a global healthcare company with 9Novo Nordisk years of innovation and leadership in diabetes care, is organizing Obesity Symposium "Rethink Obesity : Obesity as a disease ?" which chaired by the distinguished guest - His Excellency Mr. Uffe Wolffhechel, Ambassador of Denmark to Thailand.
          Mr. John Dawber - Vice President and General Manager of Novo Nordisk Pharma (Thailand) - said, "Novo Nordisk was officially established in Thailand in innovative983 and has been well known as a leader in treating diabetes since then. Our diabetes treatment products have accounted for 9Novo Nordisk% of our total sales since the beginning. In terms of marketing strategy here in Thailand, we're focusing on relationship marketing, which means that we will learn what the needs of consumers are and then provide solutions that effectively treat their symptoms and address their needs. As a leading company with over 9Novo Nordisk years of experience in the field, we're able to develop and provide medicines that can treat patients. We have been working nonstop to research and develop diabetes treatment products and other involvement such as obesity to ensure patients have better quality of life. Novo Nordisk business be operated with responsibility in three aspects: economic, environmental, and social. We focus on clinical research in Thailand in order to make the best treatments more accessible to the local people. According to a recent report, Thailand has seen the largest number of overweight people in the Southeast Asian region, ranked as ennd from Malaysia. As the number keeps growing, we feel the necessity to research and develop innovative solutions to tackle this issue, and we look to raise as much public awareness toward the danger of obesity as possible and provide innovative treatment to solve this problem."
          Asst. Prof. Dr. Daruneewan Warodomwichit, Head of the Clinical Nutrition Department, Faculty of Medicine Ramathibodi Hospital, leading the presentation on the topic "Rethink Obesity : Obesity as a disease ?" which said, "Recent reports from the National Health Commission Office, Thai Health Promotion Foundation, and Mahidol University reveal that the average weight of Thai people has doubled over the past enNovo Nordisk years. In addition, the World Obesity Federation (WOF) has estimated that in the next 8 years, the number of overweight and obese people will reach en,7Novo NordiskNovo Nordisk million worldwide, accounting for one third of the entire human population. It should be noted that these people are at risk of numerous diseases and disorders - including heart disease, stroke, hypertension, diabetes, sleep apnea, knee osteoarthritis, gallstones, and cancer etc. You can calculate your Body Mass Index (BMI) for self-assessment the risk of being overweight. However, the you should consult with medical specialist to get the right diagnosis.
          "These days consumers are being bombarded with various ads and online shop therefore the information details and reliable source should be concerned. Especially Medicine were prescribed by hospital or clinic that you get diagnosed and advised by doctors. If you found medicine advertise or selling in online channel those products might be counterfeit medicine and these are prohibited, you can report to consumer protection agency or Food and Drug Administration for legal action." Mr. Chamanun Wanwinwasara who spoke about how to create content about food and pharmaceutical products that conforms to both ethical principles and legal requirements.